Science Current Events | Science News | Brightsurf.com
 

Cancer 'turns off' important immune cells, complicating experimental vaccine therapies

August 31, 2012
New research published in the Journal of Leukocyte Biology suggests monocyte-derived dendritic cells may not be as effective in inducing desired immune responses as previously expected

Bethesda, MD-A research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems. In the report, scientists suggest that cancer, even in the very early stages, produces a negative immune response from dendritic cells, which prevent lymphocytes from working against the disease. Although problematic for cancer treatment, these flawed dendritic cells could be valuable therapeutic tools for preventing the immune system from attacking what it should not, as is the case with autoimmune disorders and organ transplants.

"Immunotherapy of cancer has been an elusive research target that, though promising, never seems to 'get there,'" said José Alexandre M. Barbuto, Ph.D., from the Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences at the University of São Paulo, in São Paulo, Brazil. "This study helps us to better understand the mechanisms by which tumors avoid immune recognition and rejection and may, therefore, teach us how to actually engage effectively the immune system in the fight against tumors, thus achieving much better clinical responses and, consequently, quality of life, in our therapeutic approaches."

To make this discovery, researchers obtained a small sample of blood from breast cancer patients, and from healthy volunteers. The blood cells were then separated and induced to become dendritic cells. Researchers then used these laboratory-generated dendritic cells to induce responses from other immune system cells, namely lymphocytes. While dendritic cells from the healthy donors induced vigorous lymphocytic responses, dendritic cells from cancer patients induced mainly the activation of a specific type of lymphocyte, a regulatory lymphocyte that works as a "brake" for other types of lymphocytes.

"Understanding why the immune system does not recognize and eliminate cancer is critical to developing effective immunotherapies to fight the disease," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Immunologists have been trying to unravel the answer to this question for decades and have realized that the problem is both on the immune system side, and because cancer cells appear to actively 'fly under the radar' avoiding immune system detection. This article offers insights into the underlying mechanisms regulating a key immune cell type, the dendritic cell, involved in initiating anti-tumor responses."

Federation of American Societies for Experimental Biology


Related Dendritic Cells Current Events and Dendritic Cells News Articles


Scripps Research Institute scientists identify trigger for crucial immune system cell
Scientists at The Scripps Research Institute (TSRI) have identified the long-sought activating molecules for a rare but crucial subset of immune system cells that help rally other white blood cells to fight infection.

The 'Cyberwar' Against Cancer Gets a Boost from Intelligent
Two years ago, Prof. Eshel Ben-Jacob of Tel Aviv University's School of Physics and Astronomy and Rice University's Center for Theoretical Biological Physics made the startling discovery that cancer, like an enemy hacker in cyberspace, targets the body's communication network to inflict widespread damage on the entire system.

'Stealth' nanoparticles could improve cancer vaccines
Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven't worked that well.

Researchers at Broad Institute and MIT engineer
Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system for in vivo genome editing experiments.

Immune system is key ally in cyberwar against cancer
Research by Rice University scientists who are fighting a cyberwar against cancer finds that the immune system may be a clinician's most powerful ally.

A better way to track emerging cell therapies using MRIs
Cellular therapeutics - using intact cells to treat and cure disease - is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination and persistence of these cells in patients without resorting to invasive procedures, like tissue sampling.

New insights on an ancient plague could improve treatments for infections
Dangerous new pathogens such as the Ebola virus invoke scary scenarios of deadly epidemics, but even ancient scourges such as the bubonic plague are still providing researchers with new insights on how the body responds to infections.

Dendritic cells affect onset and progress of psoriasis
Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine.

Reversal of type 1 diabetes in mice may eventually help humans
Investigators at the University of Cincinnati (UC) have found a therapy that reverses new onset Type 1 diabetes in mouse models and may advance efforts in combating the disease among humans.

Liver cancer vaccine effective in mice
Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
More Dendritic Cells Current Events and Dendritic Cells News Articles

Dendritic Cell Protocols (Methods in Molecular Biology)

Dendritic Cell Protocols (Methods in Molecular Biology)
by Shalin H. Naik (Editor)


Given the vital importance of immune system research, the gathering of clear, consistent, and informative protocols involving the study of dendritic cells is paramount. Bringing the popular first edition fully up to date, Dendritic Cell Protocols, Second Edition presents protocols from experts in the field that cover the basics and more complex forays into the exploration of DC development and function, both in mice and humans. The first section of the volume involving humans explores topics such as the isolation of blood DC subtypes, primary skin Langerhans cells, and the generation of gene-manipulated human DCs with the inclusion of more clinically relevant methods as well, while the second section involving rodent models delves into DC and precursor generation in vitro, isolation ex...

Dendritic Cells in Cancer

Dendritic Cells in Cancer
by Michael R Shurin (Editor), Russell D. Salter (Editor)


It covers all aspects of DC generation, function, survival and antitumor activity in the tumor environment both in vivo and in experimental in vitro systems. The goal in focusing on a spectrum of issues related to DC in cancer is to provide an extensive and expansive review rather than a collection of independent analyses from different authors. Specific topics to be covered include analysis of DC behavior in the tumor microenvironment, including endogenous and exogenous DC, multiple DC populations, molecular pathways responsible for DC dysfunction, tumor-derived factors altering DC polarization and activation, mechanisms of DC alterations, and the role of DC in tumor escape from immune recognition and elimination. Furthermore, additional chapters provide extensive analysis of the...

Dendritic Cells (Handbook of Experimental Pharmacology)

Dendritic Cells (Handbook of Experimental Pharmacology)
by Giovanna Lombardi (Editor), Yanira Riffo-Vasquez (Editor)


The understanding of the role of dendritic cells (DCs) in immune responses has come a long way since Steinmann and colleagues described these cells in 1972. - tensive research during the intervening period has provided a good understanding of the complexity of the DC system and its pivotal role in immunity. It is also now clearer how different subsets of DCs interact and regulate each other and how DC populations affect the function of other cells of the immune system. The improved understanding of their role in immune response has led to the idea that modulation of DC functions by, for example, pharmacological agents could be used as a pot- tial therapeutic approach in some pathological conditions. The actual applicability and therapeutic potential of all these approaches is yet to be...

Dendritic Cell Protocols (Methods in Molecular Biology)

Dendritic Cell Protocols (Methods in Molecular Biology)
by Stephen P. Robinson (Editor), Andrew J. Stagg (Editor)


Stephen P Robinson, MD, PhD, and Andrew Stagg, PhD, have brought together a wide range of time-proven methods for studying these dendritic cells. Many of these readily reproducible techniques deal with the problem of obtaining sufficient dendritic cells for analysis, whether by isolation from a wide vareity of tissues, or from various progenitor cell populations. Other methods describe in step-by-step fashion the techniques commonly used for analyzing aspects of dendritic cells, ranging from cell migration to antigen uptake and T cell stimulation. In addition, a few techniques explore the practical challenges involved in using dendritic cells in a clinical setting to develop novel immunotherapeueutics.

Dendritic cells and their potential role in the treatment of leukemia: Development of a clinical leukemia vaccine using dendritic cells loaded with the Wilms' tumor (WT1) gene product

Dendritic cells and their potential role in the treatment of leukemia: Development of a clinical leukemia vaccine using dendritic cells loaded with the Wilms' tumor (WT1) gene product
by Ann Van Driessche (Author)


Despite major advances in standard cancer treatment, many patients relapse or progress after a period of time. Cancer immunotherapy is being extensively investigated to provide a treatment with less side effects impacting on quality of life as compared to classical therapies. Dendritic cells (DC) are professional antigen-capturing and -presenting cells which are capable in balancing the immune system between immune stimulation and tolerance. We explored the use of dendritic cells for the development of immunotherapy in leukemia patients to stimulate and enhance T cell-mediated immune responses. Wilms’ tumor protein (WT1), overexpressed in many cancer types, was chosen as target antigen. This book describes the way a dendritic cell vaccine is produced: from the early proof of concept...

Dendritic Cells, Second Edition: Biology and Clinical Applications

Dendritic Cells, Second Edition: Biology and Clinical Applications
by Michael T. Lotze (Editor), Angus W. Thomson (Editor)


Dendritic Cells, 2nd Edition is the new edition of the extremely successful book published in 1998. With the volume of literature on dendritic cells doubling every year, it is almost impossible to keep up. This book provides the most up-to-date synthesis of the literature, written by the very best authors. It is essential reading for any scientist working in immunology, cell biology, infectious diseases, cancer, transplantation, genetic engineering, or the pharmaceutical/biotechnology industry.

* An entirely new section on DC biology is included in this edition. Also new to this edition are chapters on:
* Imaging
* Interaction of dendritic cells with viruses
* Dendritic cells and dendrikines, chemokines and the endothelium
*...

Dendritic Cells: Biology and Clinical Applications

Dendritic Cells: Biology and Clinical Applications
by Michael T. Lotze (Editor), Angus W. Thompson (Editor)


Dendritic Cells is the first definitive book on this subject, and brings together the most current information in the field for scientists and clinicians. It outlines research studies, the first reports of therapeutic applications of dendritic cells, and the enormous potential of these unique cells. Contributors are from the key research groups around the world who are working on the immunobiology of dendritic cells and in applied areas, striving to develop their therapeutic potential.

Key Features
* First book on the subject of dendritic cells, the most powerful tool for manipulating the immune system
* Discusses the origin of DCs, their function throughout the body, and how they interact with other cells
* Covers the role of DCs in...

Cell Talk: Transmitting Mind into DNA

Cell Talk: Transmitting Mind into DNA
by John E. Upledger (Author)


Craniosacral therapy (CST) has become an important modality in treating trauma and promoting wellness. With its gentle approach to working with the spine, the skull and its cranial sutures, diaphragms, and fascia, CST has proven equally useful for physical therapists, massage therapists, naturopaths, chiropractors, and osteopaths. One reason for its success has been its underlying theory, as explained by CST pioneer John Upledger. According to Upledger, bodily tissues and cells have individual memories, and traumatic memories can be stored in these cells and tissues. Cell Talk, written for the layperson, explores this concept in depth and shows practitioners how to use it in healing their patients.

The book offers simple strategies for treating disease and dysfunction by...

Characterization of the CD83 promoter/enhancer complex: in human dendritic cells

Characterization of the CD83 promoter/enhancer complex: in human dendritic cells
by Marcello Stein (Author)


CD83 is one of the best-known surface markers for mature dendritic cells (DC). As CD83 is specifically upregulated upon DC maturation, a highly cell type- and maturation status-specific gene regulation is hypothesized. To elucidate the regulation mechanisms of CD83 expression in human DC, ChIP-chip-microarray-, biocomputational-, reporter, CpG-methylation- and EMSA -analyses were performed. By these studies, a tripartite transcriptional activation complex composed of an upstream regulatory element, a minimal promoter and an enhancer was identified. Their specific arrangement and cooperation in trans, mediated by a complex framework of IRF- and NFkB-binding sites, has not been reported for any other gene so far. The characterization of the CD83 promoter complex not only allows a detailed...

Dendritic Cells in Fundamental and Clinical Immunology: Volume 2 (Advances in Experimental Medicine and Biology)

Dendritic Cells in Fundamental and Clinical Immunology: Volume 2 (Advances in Experimental Medicine and Biology)
by Jacques Banchereau (Editor), Daniel Schmitt (Editor)


These Proceedings contain the contributions of the partIcIpants of the Third International Symposium on Dendritic Cells that was held in Annecy, France, from June 19 to June 24, 1994. This symposium represented a follow-up of the first and second international symposia that were held in Japan in 1990 and in the Netherlands in 1992. Dendritic cells are antigen-presenting cells, and are found in all tissues and organs of the body. They can be classified into: (1) interstitial dendritic cells of the heart, kidney, gut, and lung;(2) Langerhans cells in the skin and mucous membranes; (3) interdigitating dendritic cells in the thymic medulla and secondary lymphoid tissue; and (4) blood dendritic cells and lymph dendritic cells (veiled cells). Although dendritic cells in each of these...

© 2014 BrightSurf.com